Thanks @SAtoe3
I was expecting really good dystrophin results as I said “something remarkable is happening in these boys muscles”.
@samfiodiving nailed it in a recent post after the quarterly when he was indicating that something remarkable is happening but it is NOT dystrophin!!!! Maybe the big factor in DMD progression is the inflammation.
I am purely guessing here but what is also interesting (maybe jumping at shadows) is the fact ANP is not coming out with the final combo results re DYSTROPHIN until after Sarepta has its 2 dances with the FDA when the adcom is considering DYSTROPHIN AS A BIOMARKER!!
Is this a coincidence?? Maybe or maybe not. Little old ANP may have been told to stay out of the way until then?? Who knows. I have seen stranger things.
Someone pointed out that Charmaine seems pretty confident that ANP is bringing this “much needed therapy to the DMD community”
The plot thickens.
- Forums
- ASX - By Stock
- Ann: PIIb DMD trial approved in Bulgaria- UK, Australia advancing
Thanks @SAtoe3I was expecting really good dystrophin results as...
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PER (ASX) to my watchlist
(20min delay)
|
|||||
Last
8.0¢ |
Change
-0.001(1.23%) |
Mkt cap ! $72.12M |
Open | High | Low | Value | Volume |
8.2¢ | 8.2¢ | 8.0¢ | $63.52K | 777.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 43377 | 8.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.2¢ | 97561 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 43377 | 0.080 |
2 | 212658 | 0.078 |
1 | 200000 | 0.077 |
3 | 91500 | 0.076 |
4 | 206988 | 0.075 |
Price($) | Vol. | No. |
---|---|---|
0.082 | 97561 | 1 |
0.083 | 214000 | 1 |
0.084 | 67142 | 2 |
0.085 | 141000 | 2 |
0.086 | 106100 | 2 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
PER (ASX) Chart |